Sixth Anniversary: The Initial Formation of a Full-Service Internet Brokerage Firm

On June 12th, Beijing time, Burning Rock Biotech was listed on NASDAQ. As a leader in the tumor genetic testing track, this company has garnered significant attention since the news of its listing was announced. Investor enthusiasm was reflected in the secondary market, with the company's stock opening at $22.8, a 38% increase from the IPO price of $16.5, and then rising rapidly. The intraday high reached $26.37, and it closed up 49.27% at $24.63, with a market capitalization exceeding $2.5 billion. It is reported that Tiger Securities acted as the underwriter for Burning Rock Biotech, successfully helping it secure over $360 million in orders. Among these, the retail side saw over ten thousand subscribers, with a subscription amount of $223 million, once again setting a new record for retail subscription in U.S. IPO on the Tiger Securities platform. This demonstrates the unique value and strong business synergy of Tiger Securities as an emerging technology investment bank.

"As entrepreneurs ourselves, we can better approach and understand Chinese startups, empathize with the pain points they face during their listing process, and provide them with customized services. Furthermore, our experienced U.S. investment banking team, with their deep understanding of the U.S. market environment and industry, can offer more targeted professional advice on finance, valuation, and other aspects for these companies. Being a listener and long-term strategic partner for Chinese concept companies, growing alongside them, is what Tiger wants to do," said a relevant person in charge of Tiger Securities' investment banking department. On June 12th, Beijing time, Burning Rock Biotech was listed on NASDAQ. As a leader in the tumor genetic testing track, this company has garnered significant attention since the news of its listing was announced. Investor enthusiasm was reflected in the secondary market, with the company's stock opening at $22.8, a 38% increase from the IPO price of $16.5, and then rising rapidly. The intraday high reached $26.37, and it closed up 49.27% at $24.63, with a market capitalization exceeding $2.5 billion. It is reported that Tiger Securities acted as the underwriter for Burning Rock Biotech, successfully helping it secure over $360 million in orders. Among these, the retail side saw over ten thousand subscribers, with a subscription amount of $223 million, once again setting a new record for retail subscription in U.S. IPO on the Tiger Securities platform. This demonstrates the unique value and strong business synergy of Tiger Securities as an emerging technology investment bank."As entrepreneurs ourselves, we can better approach and understand Chinese startups, empathize with the pain points they face during their listing process, and provide them with customized services. Furthermore, our experienced U.S. investment banking team, with their deep understanding of the U.S. market environment and industry, can offer more targeted professional advice on finance, valuation, and other aspects for these companies. Being a listener and long-term strategic partner for Chinese concept companies, growing alongside them, is what Tiger wants to do," said a relevant person in charge of Tiger Securities' investment banking department. On June 12th, Beijing time, Burning Rock Biotech was listed on NASDAQ. As a leader in the tumor genetic testing track, this company has garnered significant attention since the news of its listing was announced. Investor enthusiasm was reflected in the secondary market, with the company's stock opening at $22.8, a 38% increase from the IPO price of $16.5, and then rising rapidly. The intraday high reached $26.37, and it closed up 49.27% at $24.63, with a market capitalization exceeding $2.5 billion. It is reported that Tiger Securities acted as the underwriter for Burning Rock Biotech, successfully helping it secure over $360 million in orders. Among these, the retail side saw over ten thousand subscribers, with a subscription amount of $223 million, once again setting a new record for retail subscription in U.S. IPO on the Tiger Securities platform. This demonstrates the unique value and strong business synergy of Tiger Securities as an emerging technology investment bank.